pyrazolanthrone has been researched along with nms p715 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, Y; Daigo, Y; Dohi, K; Hashizume, H; Hato, Y; Higaki, M; Higashino, K; Ide, N; Iguchi, M; Inoue, M; Ishioka, Y; Itoh, T; Kanazawa, T; Kido, Y; Kusakabe, K; Maeda, M; Murai, H; Nakamura, Y; Okano, Y; Sakamoto, S; Sato, Y; Shiota, T; Tachibana, Y; Ueda, K; Yamamoto, T; Yasuo, K; Yoshizawa, H | 1 |
| Jiang, M; Li, C; Li, J; Liang, D; Liu, J; Sun, W; Wang, S; Yang, X; Zhang, C; Zhang, M; Zhou, X | 1 |
1 review(s) available for pyrazolanthrone and nms p715
| Article | Year |
|---|---|
Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective.
Topics: Antineoplastic Agents; Cell Cycle Proteins; Drug Design; Drug Resistance; Humans; M Phase Cell Cycle Checkpoints; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Spindle Apparatus; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2019 |
1 other study(ies) available for pyrazolanthrone and nms p715
| Article | Year |
|---|---|
Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125).
Topics: Animals; Anthracenes; Cell Cycle Proteins; Cell Line, Tumor; Crystallography, X-Ray; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Models, Molecular; Molecular Conformation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Rats; Structure-Activity Relationship | 2013 |